Literature DB >> 15684210

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.

Axel Finckh, Mark D Aronson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684210     DOI: 10.7326/0003-4819-142-3-200502010-00013

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  11 in total

1.  Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer.

Authors:  Naveen K Thakral; Alok R Ray; Dipak K Majumdar
Journal:  J Mater Sci Mater Med       Date:  2010-06-10       Impact factor: 3.896

2.  Understanding the COX-2/NSAID dilemma.

Authors:  Sanford H Roth
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  NSAID hysteria--Chicken Little revisited.

Authors:  John A Goldman; Sanford S Hartman
Journal:  MedGenMed       Date:  2005-04-13

4.  Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis.

Authors:  Anjana K Negi; Shevali Kansal; Archana Bhatnagar; Navneet Agnihotri
Journal:  Tumour Biol       Date:  2013-09-21

5.  Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study.

Authors:  Souhila Bouaziz-Terrachet; Amel Toumi-Maouche; Boubekeur Maouche; Safia Taïri-Kellou
Journal:  J Mol Model       Date:  2010-03-17       Impact factor: 1.810

Review 6.  TAM receptor deficiency affects adult hippocampal neurogenesis.

Authors:  Rui Ji; Lingbin Meng; Qiutang Li; Qingxian Lu
Journal:  Metab Brain Dis       Date:  2014-12-10       Impact factor: 3.584

7.  Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

Authors:  Bruno P Imbimbo; Vincenzo Solfrizzi; Francesco Panza
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

8.  Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer.

Authors:  Anjana Kumari Negi; Archana Bhatnagar; Navneet Agnihotri
Journal:  Inflammopharmacology       Date:  2016-01-09       Impact factor: 4.473

9.  Age and rising rates of cyclooxygenase-2 inhibitor use. Results from a national survey.

Authors:  Michael A Steinman; Kenneth R McQuaid; Kenneth E Covinsky
Journal:  J Gen Intern Med       Date:  2006-02-22       Impact factor: 5.128

10.  The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres.

Authors:  Naveen K Thakral; Alok R Ray; Daniel Bar-Shalom; André Huss Eriksson; Dipak K Majumdar
Journal:  Int J Nanomedicine       Date:  2011-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.